Amagqwetha amangalela inkampani yemichiza yaseSwitzerland iSyngenta bacela iphaneli yezomthetho yase-US ukuba idibanise ngaphezulu kweshumi elinesihlanu lezimangalo ezifanayo phantsi kweliso lejaji yomanyano eCalifornia. Eli nyathelo luphawu oluchazayo lokwandiswa kwezimangalo ezibanga ukuba imveliso yokubulala ukhula yenkampani ibangela isifo sikaParkinson.
Ngokutsho kwisindululo, ifayilishwe umhla we-7 ku-Epreli yi-Texas-based Fears Nachawati firm firm kunye ne-US Judicial Panel kwi-Multidistrict Litigation, kungoku nje kukho ubuncinci amatyala ali-14 afakwe ziifemi ezisibhozo zomthetho kwiinkundla zomdibaniso ezahlukeneyo ezintandathu kwilizwe liphela. Amacala onke afakwe egameni labamangali abafunyaniswe benesifo se-neurodegenerative, kwaye batyhola ukubhencwa kwababulali bokhula baseSyngenta abenziwe ngemichiza ebizwa ngokuba yiparaquat yesifo. Amanye amatyala aliqela enza izityholo ezifanayo zilindelwe kwiinkundla zamazwe.
"La matyala ngawona magqwetha alungeleleneyo kwityala elingaphambi kokuthethwa kwetyala kuba avela kwityhefu enye enetyhefu edala isifo esikhubazekayo esibangelwa kukungaziphathi kakuhle kwabamangalelwa abathathu," uloyiko uNachawati ngokufutshane ukuxhasa yokuhamba kwayo ithi. "UMovant ulindele ukuba inani lamatyala afanayo afakwe kwiinkundla zikarhulumente kunye nelizwe liphela lizakwanda ngokukhawuleza."
Isindululo sifuna ukugqithiselwa ngokukodwa kwiJaji u-Edward Chen kwiNkundla yeSithili sase-US kwiSithili saseMantla saseCalifornia.
UMajed Nachawati, iqabane lenkampani eyoyikayo iNachawati, uthe inkampani isaphanda ubungakanani nobubanzi besimangalo sisonke kodwa ikholelwa kwelokuba ukumiswa kweparaquat ngokuchasene neSyngenta “kuzakubaluleka kwaye kubaluleke kwindalo…”
"Kungekudala, kuzakubakho isimangalo kwiinkundla zomanyano kwilizwe liphela," utshilo uNachawati.
Amagqwetha abamangali bazakufuna amaxwebhu angaphakathi enkampani kunye nokufakwa kwamagosa eenkampani ahambelana "nokuvavanywa, ukuyilwa, ukufakwa iileyibhile, ukuthengiswa, kunye nokukhuselwa kweeparaquat herbicides," kunye nophando oluhlangeneyo kunye nokuvavanywa kobutyhefu kunye nokukhuseleka kweparaquat yayo. iimveliso.
IMiller Firm yaseVirginia, encedise ukukhokelela kwisimangalo seRoundup ngokuchasene neMonsanto esikhokelele kwisigqibo se- $ 11 lezigidi kunye nomnini weMonsanto uBayer AG, uphakathi kweefemu zomthetho ezijoyina isimangalo separaquat. Inkampani yaseMiller ixhasa iinzame zokudibanisa iintshukumo zomdibaniso eCarlifonia, apho amawaka amatyala eRoundup adityanisiwe kwenkqubo yamatyala, ngokwegqwetha elikhokelayo lenkampani uMike Miller.
"Siqinisekile ukuba inzululwazi iyaluxhasa ngamandla unxibelelwano phakathi kwe-paraquat kunye nokutshatyalaliswa kwesifo sika-Parkinson," utshilo uMiller ngesindululo. "ISithili saseMantla saseCalifornia sinezixhobo ezifanelekileyo zokujongana nala matyala."
Amatyala ngokuchasene neSyngenta ukwabiza i-DRM Phillips Chemical Co njengommangalelwa. I-DRM isasazwa kwaye ithengise iimveliso ze-Gramoxone paraquat e-United States ngokuqala ngesivumelwano nomanduleli wase-Syngenta obizwa ngokuba yi-Imperial Chemical Industries (ICI), eyazisa nge-Gramoxone esekwe yiparaquat ngo-1962. Phantsi kwesivumelwano selayisensi, i-DRM yayinelungelo lokwenza, ukusebenzisa, kwaye uthengise ukwenziwa kweparaquat eMelika
USyngenta noChevron bayaziphika izityholo.
USyngenta uthi iimveliso zayo zeparaquat zivunyiwe njenge “zikhuselekile kwaye zisebenza” ngaphezulu kweminyaka engama-50 kwaye “iya kuzikhusela” ngamandla. ISyngenta yeyabanini beChina National Chemical Corporation, eyaziwa ngokuba yiChemChina.
Izifundo zesayensi
Isifo sikaParkinson sisifo esinganyangekiyo esiqhubela phambili esichaphazela iiseli zemithambo-luvo kwingqondo, sikhokelela kumatyala aphambili kukudodobala komzimba kakhulu kwaye kuhlala kuluphazamiseko engqondweni. Iingcali ezininzi zika-Parkinson zithi esi sifo sinokubangelwa luluhlu lwezinto, kubandakanya ukubhencwa kwizibulali zinambuzane ezinje nge paraquat, kunye nezinye iikhemikhali.
Izifundo ezininzi zesayensi ziye idityaniswe neparaquat kwiParkinson's, kubandakanya isifundo esikhulu samafama ase-US ngokudibeneyo abekwa esweni ziiarhente zikarhulumente zase-US ezininzi. Oko Uphando ngo-2011 uxele ukuba abantu abasebenzisa i-paraquat baphindwe kabini amathuba okuphuhlisa isifo sika-Parkinson njengabantu abangasisebenzisanga.
"Izifundo ezininzi ze-epidemiological kunye nezilwanyana zidibanise i-paraquat nesifo sika-Parkinson," kusho uDorsey Ray, uprofesa we-neurology kunye nomlawuli we-Centre for Human Experimental Therapeutics kwiYunivesithi yaseRochester eNew York. UDorsey ukwangumbhali we incwadi malunga nokuthintela kunye nokunyanga isifo sikaParkinson.
"Ubungqina obudibanisa iparaquat nesifo sikaParkinson yeyona nto yomeleleyo kuyo nayiphi na into yokubulala izinambuzane esetyenziswa ngokuxhaphakileyo," utshilo.
Olunye uphononongo alufumananga unxibelelwano olucacileyo phakathi kweparaquat kunye neParkinson kunye neSyngenta iqinisekisa ukuba olona phando lwamva nje nolunegunya alubonisi nxibelelwano.
Ewe kunjalo, isifundo papashwe kwi2020 ifumene unxibelelwano phakathi kwezinye izitshabalalisi kunye neParkinson's, kodwa abukho ubungqina obomeleleyo obubonisa iparaquat ebangela esi sifo.
Uvavanyo oluzayo
Ityala elinye elifakwe kwinkundla yelizwe licwangciselwe ukuba lixoxwe kwinyanga ezayo. IHoffman V. Syngenta icwangciselwe ukuxoxwa kwetyala ngoMeyi 10 eSt. Inkomfa yobume icwangciselwe ukuphela kwale nyanga.
Igqwetha laseMissouri uSteve Tillery, omele abamangali kwityala lika-Hoffman kunye nabanye abamangalelwa kwamanye amaphepha-mthetho, uthe nangona uSyngenta eqinisekile, uqokelele ubungqina obuquka iirekhodi zenkampani zangaphakathi ezibonisa ukuba iSyngenta yazi amashumi eminyaka ukuba Imveliso ibangela isifo sikaParkinson.
“Akufanelekanga ukuba bayayithengisa le mveliso, utshilo uTillery. "Le khemikhali kufuneka ingabikho kwimarike."